PON-dering differences in HDL function in coronary artery disease

Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease

(2011) Christian Besler et al.   JOURNAL OF CLINICAL INVESTIGATION

Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

(2011) Amit V. Khera et al.   NEW ENGLAND JOURNAL OF MEDICINE

The promise of apolipoprotein A-I mimetics

(2011) Armando J Mendez   Current Opinion in Endocrinology Diabetes and Obesity

Signaling by the High-Affinity HDL Receptor Scavenger Receptor B Type I

(2010) Sonika Saddar et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Modifying Apolipoprotein A-I by Malondialdehyde, but Not by an Array of Other Reactive Carbonyls, Blocks Cholesterol Efflux by the ABCA1 Pathway

(2010) Baohai Shao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Discovery and Validation of New Molecular Targets in Treating Dyslipidemia: The Role of Human Genetics

(2010) Amit V. Khera et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Paraoxonase Variants Relate to 10-Year Risk in Coronary Artery Disease

(2009) Jakub J. Regieli et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Update on strategies to increase HDL quantity and function

(2009) Danielle Duffy et al.   Nature Reviews Cardiology

Rapid regression of atherosclerosis: insights from the clinical and experimental literature

(2008) Kevin Jon Williams et al.   Nature clinical practice. Cardiovascular medicine